What is breast cancer?
- Medical Review: Regina Hampton, MD, FACS
Breast cancer is uncontrolled growth of abnormal cells in the breast. Breast cancer is one of many types of cancer, and it’s the second most common cancer after skin cancer (among women) in the United States. While women are much more likely to develop breast cancer than men, men can be diagnosed with breast cancer, too.
How does breast cancer happen?
Our bodies are made up of trillions of cells. Healthy cells grow and divide to form new cells as the body needs them. The cells die when they are damaged or old. In cancerous cells, abnormal changes in the genes that control cell growth can cause cells to divide out of control. The damaged or old cells don’t die as they should. Malignant is another word used to describe cancerous cells. These cells can sometimes form into groups, called tumors.
In some cases, cancer cells stay confined to the breast (sometimes called “local to the breast”). Over time, it’s possible for some cancer cells to invade the bloodstream or lymph system and spread to other parts of the body. Cancer spread to another part of the body is called metastasis.
If you or someone you love has been diagnosed with breast cancer, we know how overwhelming it can feel. For many people, it’s unexpected. But you’re never alone. LBBC is here for you with information, support, and community, no matter where you are on the diagnosis and treatment path.
On this page
Types of breast cancer
Breast cancers usually start in the lobules or ducts of the breast. The lobules are glands that make breast milk. Ducts carry the milk from the lobules to the nipple. Breast cancer in the ducts is called ductal carcinoma. In the lobules, it’s called lobular carcinoma. Carcinoma means cancer that begins in the skin or tissues that cover internal organs.
There are two main types of breast cancer, noninvasive and invasive, that include carcinomas of the ducts and lobules.
Noninvasive breast cancer
Noninvasive breast cancer is called in situ carcinoma. In breast cancer, in situ means that the cancer hasn’t spread beyond the ducts or lobules. There is one kind of noninvasive breast cancer: ductal carcinoma in situ, also called DCIS. A diagnosis of DCIS means that cancer cells are found in the lining of the milk ducts. DCIS is also called intraductal carcinoma.
Lobular carcinoma in situ, also called LCIS, is a noninvasive breast change that can happen inside a breast lobule. Although LCIS has carcinoma in its name, it is not cancer. It is a high-risk marker of increased risk of developing breast cancer in the future. If left untreated, LCIS cells don’t usually spread beyond the lobule or become cancer. But having LCIS does increase the risk of developing an invasive breast cancer in the future.
Learn more about DCIS and LCIS.
Invasive breast cancer
Invasive means that the cancer has grown through the lining of a duct or lobule into the surrounding breast tissue. There are two types of invasive breast cancer:
- Invasive ductal carcinoma (IDC) begins in the ducts and spreads to, or invades, nearby breast tissue outside the ducts. IDC is the most common type of invasive breast cancer.
- Invasive lobular carcinoma (ILC) begins in the lobules and invades nearby breast tissue.
Invasive breast cancer can also spread beyond the breast to lymph nodes and other parts of the body.
Visit the types of breast cancer page to learn more.
Characteristics of breast cancer cells
Breast cancer cells can have many different characteristics that can affect treatment choices. After a tissue biopsy, your doctor will share a pathology report with you that explains how the cells look and behave. You may see cell characteristics described as hormone receptor-positive or negative and HER2-positive or negative.
- Hormone receptor-positive breast cancer is breast cancer that needs the hormones estrogen and/or progesterone to grow. These breast cancers are usually treated with hormonal therapy.
- HER2-positive breast cancer is breast cancer that makes too much of the HER2 protein, and too many HER2 receptors. While HER2-positive breast cancers can be more aggressive than other breast cancers, there are many effective anti-HER2 breast cancer treatments.
- Triple-negative breast cancer is invasive breast cancer that is negative for hormone receptors and HER2 receptors. These cancers grow and spread faster than other breast cancers. While treatment options for triple-negative breast cancer used to be limited to surgery, chemotherapy, and radiation therapy, more treatments are becoming available. Chemotherapy is usually a required part of treatment, either before or after surgery.
There are also breast cancers that are considered less common, including male breast cancer, inflammatory breast cancer, and Paget’s disease. Still, these breast cancers have no less of an impact on a person:
- Male breast cancer includes the same types of breast cancer that happen in women: DCIS, IDC, and ILC. In 2021, it was estimated that 2,650 men in the U.S. would be diagnosed with breast cancer.
- Inflammatory breast cancer (IBC) is an aggressive type of invasive breast cancer. IBC symptoms are usually different than those of other types of breast cancer. IBC symptoms include swelling of the breast, redness on a large area of the breast, and thickened breast skin that may look like an orange peel. People with IBC don’t usually have a breast lump. These cancers are often mistaken for breast infection, but do not respond to antibiotics. This can delay diagnosis, so if you are having these symptoms, it’s important to talk with your doctor about testing for IBC.
- Paget’s disease of the breast usually affects the nipple and the areola (the darker circle of skin around the nipple). Most people diagnosed with Paget disease also have at least one other tumor in the affected breast.
Symptoms
Common symptoms of breast cancer include:
- A lump in the breast
- Swelling of all or part of the breast
- Skin dimpling or puckering
- Breast or nipple pain
- Nipple that turns inward
- Red, dry, flaking, or thickened nipple
- Nipple discharge that is not breast milk, with or without bleeding
- Swollen lymph nodes under the arm or around collar bone
- Pain in the organ if the cancer metastasizes
Learn more about symptoms of breast cancer.
Risk factors
Here are some of the things that can increase the risk of breast cancer. While some of these can’t be controlled, some can:
- Being born female
- Getting older (risk increases after age 55)
- Personal history of certain breast conditions or breast cancer
- Certain kinds of breast lesions (abnormal changes in the breast tissue that you or your doctor can feel, or that can be seen on an imaging test)
- Family history of breast cancer
- Inherited genetic mutations, such as BRCA1 or BRCA2
- Radiation exposure to breasts or chest
- Having dense breasts
- Starting menstrual periods early
- Beginning menopause at an older age
- Having been exposed to diethylstilbestrol (a drug used to lower risk of miscarriage)
- Lack of exercise
- Post-menopausal weight gain
- Drinking alcohol
- Taking some kinds of hormone replacement therapy after menopause (if taken for more than 5 years)
Reducing the risk of breast cancer
Right now, there is no sure way to prevent breast cancer. But there are many things you can do to reduce your risk, including:
- Avoiding or limiting alcohol use
- Exercising on a regular basis
- Keeping a healthy weight
- Limiting use of birth control that uses hormones
- Limiting postmenopausal hormone replacement therapy
- Breastfeeding, if possible, if you have children
It’s important to talk with your doctor about your own personal risk of developing breast cancer, and how your choices about birth control, having children or not having children, breastfeeding, and using hormone replacement therapy might affect your risk.
What if I’m at high risk?
If you’ve had genetic testing and have tested positive for a gene mutation such as BRCA1 or BRCA2, or if you have a sibling or parent who has tested positive, you are considered to have a high risk for breast cancer.
There are risk-reducing options for people who live with a high risk, including using preventive medicines. Preventive medicines can include hormonal therapies such as tamoxifen, raloxifene, or aromatase inhibitors. You and your health care team may also discuss the option of having prophylactic, or preventive, surgery, including mastectomy.
Learn more about our resources for high-risk and concerned individuals.
Diagnosis
If tests, such as mammogram or ultrasound, suggest that breast cells could be cancerous, a doctor will likely recommend another test called a biopsy. During a biopsy, a doctor removes a small amount of breast tissue. The tissue sample is sent to a lab, where a pathologist (a doctor who analyzes tissue under a microscope) can look to see if the tissue has cancer cells. Sometimes more tests, such as MRI, are needed after a biopsy to get more information.
If cancer cells are found, they are tested to find out what makes the cancer grow, how fast it is growing, and whether the cancer is confined to the breast tissue or may have spread to other areas of the body. The results are included in your pathology report. You and your doctors can use the information on the report to make treatment decisions.
You can learn more about mammograms, biopsies, and other tests in our section on testing. It’s also important to know that free or low-cost mammograms are available through programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Breast cancer stages
Doctors use a system called staging after they diagnose cancer. The cancer’s stage describes:
- The size of the cancer
- Whether a lymph node or nodes near the breast contain cancer
- Whether the cancer has spread to other parts of the body
- Characteristics of the cancer, such as the presence or absence of hormone or HER2 receptors
- The grade of the cancer, which describes how much the cancer cells look like normal cells
The stage of cancer helps doctors determine how serious the breast cancer is and how best to treat it. There are five stages of breast cancer: 0 to IV (4). In general, the lower the number, the less the cancer has spread.
Stage is one piece of information doctors use to understand how well a treatment might work for you and to determine prognosis information. Stage, along with other factors, including advances in treatment, is also used to estimate survival rates.
If you’ve been diagnosed with breast cancer and you’re concerned about survival rates, you’re not alone. Lots of people are. But it’s important to know that many factors are involved in looking at life expectancy, and it’s not possible to predict exactly how long someone with breast cancer will live. These factors include if, and how far, the cancer has spread in the body and how the cancer is behaving. It’s also important to keep in mind that if you’re looking at numbers that represent survival rates (statistics), these numbers are related to people diagnosed and treated at least 5 years ago. Statistics help cancer researchers understand how breast cancer affects large groups of people, but not any individual person.
Not everyone is interested in reading about breast cancer prognosis. This is completely understandable. But if this topic is important to you, you can visit Breast cancer life expectancy to learn more.
Treatment options
Here are some of the most common treatment options for breast cancer:
- Surgery removes as much breast cancer as possible and lets doctors know more information about the cancer. Types of surgery include lumpectomy and mastectomy.
- Radiation therapy destroys cancer cells by directing high-energy x-rays at the cancer.
- Chemotherapy destroys cells that are growing or dividing quickly, including cancer cells. Chemotherapy also affects healthy cells, which is why it often causes side effects.
- Hormonal therapy blocks or lowers hormones that help hormone receptor-positive breast cancers to grow.
- Targeted therapy interferes with cancer cell growth by targeting cancer cells that have certain proteins or markers, or by targeting a process in the body that helps cancer cells grow.
- Immunotherapy uses the body’s immune system to find and destroy cancer cells.
For more information on the above treatments and more, visit Treatments.
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- coinsurance
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- copayments
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- deductible
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in network
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- out of network
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- preauthorization
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- premium
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator